デフォルト表紙
市場調査レポート
商品コード
1427776

皮膚科OTC医薬品の世界市場レポート2024

Dermatology OTC Medications Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.96円
皮膚科OTC医薬品の世界市場レポート2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

皮膚科OTC医薬品の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.5%の年間複合成長率(CAGR)で190億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、皮膚の健康に対する意識の高まり、世界の高齢化人口の増加、環境要因、持続可能性と清潔な美しさへの注目、遠隔医療や遠隔診療の導入によるものと考えられます。予測期間中に予想される主な動向には、ニッチな症状別製品の出現、性別にとらわれないスキンケアの人気、多機能製品の普及、微生物に優しいスキンケアの促進、CBD入り製品の導入などが含まれます。

予想される皮膚異常の増加により、将来の皮膚科用市販薬(OTC)薬市場の成長が促進されると予想されます。皮膚の異常とは、皮膚の異常な病変や外観のことを指しますが、皮膚科の市販薬は、このような異常を治療し、皮膚を正常な状態に戻すために利用されます。乾癬などの症状を含むさまざまな皮膚異常を治療する必要性が高まっているため、市販の皮膚科薬の需要が増加しています。たとえば、2021年 8月の時点で、米国疾病管理センター(CDC)は、米国で750万人以上、世界中で1億2,500万人以上が蔓延している慢性皮膚皮膚炎である乾癬に罹患していると報告しました。したがって、皮膚異常の急増は、皮膚科OTC医薬品市場の成長を促進する重要な要因です。

eコマースの拡大は、予見可能な将来における皮膚科OTC医薬品市場の成長を促進する上で重要な役割を果たしています。eコマースは、インターネット上で商品やサービスをオンラインで売買することを意味し、皮膚科のOTC医薬品ブランドは地域の境界を越えて市場範囲を広げることができます。このプラットフォームにより、企業は自社の製品を世界中のユーザーに向けてマーケティングおよび販売できるようになり、従来の小売チャネルでは特定の製品を入手できない消費者にアクセスを提供できます。たとえば、米国国勢調査局が発表した2023年のデータによると、eコマースの売上高は、2022年の第3四半期から2023年の第3四半期までに7.6パーセント増加しました。したがって、eコマースとオンライン薬局の拡大は、 皮膚科OTC医薬品市場を牽引する準備が整っています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の皮膚科OTC医薬品市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 錠剤とカプセル
  • オイルジェル
  • クリームと軟膏
  • その他のタイプ
  • 世界の皮膚科OTC医薬品市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 皮膚炎
  • ニキビ
  • 乾癬
  • 皮膚の漂白
  • 抗真菌性
  • イボ除去剤
  • その他の適応症
  • 世界の皮膚科OTC医薬品市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 外用
  • 経口
  • 世界の皮膚科OTC医薬品市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • オンライン流通
  • オフライン流通

第7章 地域および国の分析

  • 世界の皮膚科OTC医薬品市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の皮膚科OTC医薬品市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 皮膚科OTC医薬品市場の競合情勢
  • 皮膚科OTC医薬品市場企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • AbbVie Inc.
    • Bayer AG
    • Novartis AG

第31章 その他の大手および革新的な企業

  • Bristol Myers Squibb Co
  • GlaxoSmithKline Plc
  • Acella Pharmaceuticals LLC
  • Eli Lilly and Company
  • Amgen Inc.
  • Allergan plc
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Sun Pharmaceutical Industries Inc.
  • Perrigo Company PLC
  • Galderma SA
  • Dr. Reddy's Laboratories Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13620

Dermatology over-the-counter (OTC) medications are non-prescription drugs designed for the prevention and treatment of conditions affecting the skin, hair, nails, mouth, and genitalia. These medications are safely and effectively used by the public without the need for consultation with a healthcare practitioner.

The primary forms of dermatology OTC medications include tablets and capsules, oils, gels, creams, ointments, and other formulations. Tablets are solid dosage forms containing drugs, either with or without excipients, while capsules are solid pharmaceutical dosage forms enclosed in a gelatin shell or a suitable material, offering a variety of shapes. An example of an over-the-counter medication is cetirizine, used to address allergy symptoms such as itchy eyes. Dermatology OTC medications are employed to treat various conditions, including dermatitis, acne, psoriasis, skin bleaching, anti-fungal treatments, wart removal, and others. These medications are primarily administered through topical and oral routes and are made available through distribution channels such as online and offline retail outlets.

The dermatology OTC medications market research report is one of a series of new reports from The Business Research Company that provides dermatology OTC medications statistics, including the dermatology OTC medications industry global market size, regional shares, competitors with a dermatology OTC medications market share, detailed dermatology OTC medications market segments, market trends, and opportunities, and any further data you may need to thrive in the dermatology OTC medications industry. This dermatology OTC medications market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dermatology otc medications market size has grown steadily in recent years. It will grow from $15.32 billion in 2023 to $15.96 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The expansion observed in the historical period can be ascribed to regulatory changes, a desire for convenience, the impact of skincare trends, consumer-driven demand, as well as marketing and advertising efforts.

The dermatology otc medications market size is expected to see steady growth in the next few years. It will grow to $19.06 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The anticipated growth in the forecast period can be credited to increasing awareness of skin health, a growing global aging population, environmental factors, a focus on sustainability and clean beauty, as well as the adoption of telemedicine and remote consultation. Key trends expected in the forecast period encompass the emergence of niche condition-specific products, the popularity of gender-neutral skincare, the prevalence of multi-functional products, the promotion of microbiome-friendly skincare, and the introduction of CBD-infused products.

The anticipated increase in skin abnormalities is expected to drive the growth of the dermatology over-the-counter (OTC) medication market in the future. Skin abnormalities refer to unusual skin lesions or appearances, and OTC drugs in dermatology are utilized to treat such abnormalities and restore skin to a normal state. The demand for over-the-counter dermatology medications is on the rise due to the growing need for treating various skin abnormalities, including conditions such as psoriasis. For example, as of August 2021, the Centers for Disease Control (CDC) reported that more than 7.5 million people in the USA and over 125 million people globally were affected by psoriasis, a prevalent chronic cutaneous dermatitis. Hence, the surge in skin abnormalities is a significant factor propelling the growth of the dermatology OTC medication market.

The expansion of e-commerce is playing a substantial role in driving the growth of the dermatology OTC medications market in the foreseeable future. E-commerce, which involves the online buying and selling of goods and services over the internet, enables dermatology OTC medication brands to broaden their market reach beyond local boundaries. This platform allows companies to market and sell their products to a global audience, providing access to consumers who may not have availability to specific products through traditional retail channels. For instance, according to the 2023 data released by the United States Census Bureau, e-commerce sales witnessed a 7.6 percent increase from the third quarter of 2022 to the third quarter of 2023. Therefore, the expansion of e-commerce and online pharmacies is poised to drive the dermatology OTC medications market.

Prominent companies in the dermatology over-the-counter (OTC) medications market are actively introducing innovative drugs, such as anti-fungal treatment solutions, to enhance their market profitability. An example of this is Bayer AG, a Germany-based pharmaceutical company, which launched Canesten in May 2022. Canesten, available in various forms such as cream, topical solution, and combination products, serves as an antifungal medication. It is designed to treat fungal skin infections, including vaginal thrush, ringworm, athlete's foot, diaper rash, and sweat rash. The active ingredient in Canesten products is clotrimazole, an antifungal agent that both kills and prevents the growth of fungus. Notably, Canesten is an over-the-counter (OTC) medication considered generally safe for use during pregnancy or while nursing.

Major players in the dermatology OTC medications market are strategically emphasizing the development of sustainable and clean offerings to attract customers. With consumers increasingly prioritizing environmentally friendly skincare solutions, companies are incorporating elements such as eco-friendly packaging, cruelty-free formulations, and minimal environmental impact. An illustration of this trend is seen in the initiative by the Honest Company, a US-based personal skincare products company, which introduced sustainable beauty packaging for its skincare products in July 2021. The initiative involved updating over 100 skincare units (SKUs) to use 100% recyclable cartons made from upcycled sugarcane byproduct. Changes to primary packaging, such as glass droppers, aluminum tubes, tin compacts, PCR materials, and mono-material components, aimed to utilize more environmentally friendly materials.

In February 2022, Taro Pharmaceutical Industries Ltd., a US-based pharmaceutical company, acquired Alchemee for an undisclosed amount. This strategic move positions Taro to strengthen its presence in the over-the-counter dermatology market by incorporating Alchemee's assets and resources, including the Proactiv brand. Additionally, Taro gains access to Alchemee's team expertise in omnichannel marketing. Alchemee, a US-based health, wellness, and fitness company specializing in skin health, direct marketing, and acne, enhances Taro's capabilities in the dermatology OTC medications market.

Major companies operating in the dermatology otc medications market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Bristol Myers Squibb Co, GlaxoSmithKline PLC, Acella Pharmaceuticals LLC, Eli Lilly and Company, Amgen Inc., Allergan PLC, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Inc., Perrigo Company PLC, Galderma S.A., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Inc., Lupin Limited, LEO Pharma A/S, Almirall S.A., Concert Pharmaceuticals, Arcutis Biotherapeutics, Dermavant Sciences, Roivant Sciences Inc

North America was the largest region in the dermatology OTC medications market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatology otc medications market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dermatology otc medications market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dermatology OTC medication market consists of sales of roasted moisturizers, shampoo, and acne products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dermatology OTC Medications Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dermatology otc medications market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dermatology otc medications ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatology otc medications market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Tablets And Capsules; Oils Gels; Creams And Ointments; Other Types
  • 2) By Indication: Dermatitis; Acne; Psoriasis; Skin Bleaching; Anti-Fungal; Wart Remover; Other Indications
  • 3) By Route Of Administration: Topical; Oral
  • 4) By Distribution Channel: Online Distribution; Offline Distribution
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dermatology OTC Medications Market Characteristics

3. Dermatology OTC Medications Market Trends And Strategies

4. Dermatology OTC Medications Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Dermatology OTC Medications Market Size and Growth

  • 5.1. Global Dermatology OTC Medications Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Dermatology OTC Medications Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Dermatology OTC Medications Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Dermatology OTC Medications Market Segmentation

  • 6.1. Global Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Tablets And Capsules
  • Oils Gels
  • Creams And Ointments
  • Other Types
  • 6.2. Global Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dermatitis
  • Acne
  • Psoriasis
  • Skin Bleaching
  • Anti-Fungal
  • Wart Remover
  • Other Indications
  • 6.3. Global Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Topical
  • Oral
  • 6.4. Global Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Online Distribution
  • Offline Distribution

7. Dermatology OTC Medications Market Regional And Country Analysis

  • 7.1. Global Dermatology OTC Medications Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Dermatology OTC Medications Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Dermatology OTC Medications Market

  • 8.1. Asia-Pacific Dermatology OTC Medications Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Dermatology OTC Medications Market

  • 9.1. China Dermatology OTC Medications Market Overview
  • 9.2. China Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Dermatology OTC Medications Market

  • 10.1. India Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Dermatology OTC Medications Market

  • 11.1. Japan Dermatology OTC Medications Market Overview
  • 11.2. Japan Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Dermatology OTC Medications Market

  • 12.1. Australia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Dermatology OTC Medications Market

  • 13.1. Indonesia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Dermatology OTC Medications Market

  • 14.1. South Korea Dermatology OTC Medications Market Overview
  • 14.2. South Korea Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Dermatology OTC Medications Market

  • 15.1. Western Europe Dermatology OTC Medications Market Overview
  • 15.2. Western Europe Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Dermatology OTC Medications Market

  • 16.1. UK Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Dermatology OTC Medications Market

  • 17.1. Germany Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Dermatology OTC Medications Market

  • 18.1. France Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Dermatology OTC Medications Market

  • 19.1. Italy Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Dermatology OTC Medications Market

  • 20.1. Spain Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Dermatology OTC Medications Market

  • 21.1. Eastern Europe Dermatology OTC Medications Market Overview
  • 21.2. Eastern Europe Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Dermatology OTC Medications Market

  • 22.1. Russia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Dermatology OTC Medications Market

  • 23.1. North America Dermatology OTC Medications Market Overview
  • 23.2. North America Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Dermatology OTC Medications Market

  • 24.1. USA Dermatology OTC Medications Market Overview
  • 24.2. USA Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Dermatology OTC Medications Market

  • 25.1. Canada Dermatology OTC Medications Market Overview
  • 25.2. Canada Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Dermatology OTC Medications Market

  • 26.1. South America Dermatology OTC Medications Market Overview
  • 26.2. South America Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Dermatology OTC Medications Market

  • 27.1. Brazil Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Dermatology OTC Medications Market

  • 28.1. Middle East Dermatology OTC Medications Market Overview
  • 28.2. Middle East Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Dermatology OTC Medications Market

  • 29.1. Africa Dermatology OTC Medications Market Overview
  • 29.2. Africa Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Dermatology OTC Medications Market Competitive Landscape And Company Profiles

  • 30.1. Dermatology OTC Medications Market Competitive Landscape
  • 30.2. Dermatology OTC Medications Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Dermatology OTC Medications Market Other Major And Innovative Companies

  • 31.1. Bristol Myers Squibb Co
  • 31.2. GlaxoSmithKline Plc
  • 31.3. Acella Pharmaceuticals LLC
  • 31.4. Eli Lilly and Company
  • 31.5. Amgen Inc.
  • 31.6. Allergan plc
  • 31.7. Viatris Inc.
  • 31.8. Teva Pharmaceutical Industries Ltd.
  • 31.9. Mylan N.V.
  • 31.10. Astellas Pharma Inc.
  • 31.11. Bausch Health Companies Inc.
  • 31.12. Sun Pharmaceutical Industries Inc.
  • 31.13. Perrigo Company PLC
  • 31.14. Galderma S.A.
  • 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Dermatology OTC Medications Market Competitive Benchmarking

33. Global Dermatology OTC Medications Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Dermatology OTC Medications Market

35. Dermatology OTC Medications Market Future Outlook and Potential Analysis

  • 35.1 Dermatology OTC Medications Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Dermatology OTC Medications Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Dermatology OTC Medications Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer